163 related articles for article (PubMed ID: 118705)
1. Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.
Fass RJ; Barnishan J
Antimicrob Agents Chemother; 1979 Nov; 16(5):622-4. PubMed ID: 118705
[TBL] [Abstract][Full Text] [Related]
2. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum.
Reimer LG; Stratton CW; Reller LB
Antimicrob Agents Chemother; 1981 Jun; 19(6):1050-5. PubMed ID: 6791584
[TBL] [Abstract][Full Text] [Related]
3. Minimal inhibitory concentrations of broad spectrum beta-lactam antibiotics for bacterial control strains.
Fass RJ; Helsel VL; Wright CA
Diagn Microbiol Infect Dis; 1983 Mar; 1(1):85-8. PubMed ID: 6423341
[TBL] [Abstract][Full Text] [Related]
4. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
5. Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.
Huband MD; Ito A; Tsuji M; Sader HS; Fedler KA; Flamm RK
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):198-200. PubMed ID: 28410852
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.
Muhvich KH; Park MK; Myers RA; Marzella L
Antimicrob Agents Chemother; 1989 Sep; 33(9):1526-30. PubMed ID: 2510593
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
8. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Cherne JE; Peterson LR
Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
[TBL] [Abstract][Full Text] [Related]
9. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
[TBL] [Abstract][Full Text] [Related]
10. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
11. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
[TBL] [Abstract][Full Text] [Related]
12. Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa.
Fass RJ; Barnishan J
Antimicrob Agents Chemother; 1979 Oct; 16(4):434-8. PubMed ID: 117746
[TBL] [Abstract][Full Text] [Related]
13. New derivatives of benzimidazole and their antimicrobial activity.
Cetínkaya E; Alici B; Gök Y; Durmaz R; Günal S
J Chemother; 1999 Apr; 11(2):83-9. PubMed ID: 10326736
[TBL] [Abstract][Full Text] [Related]
14. Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci.
Mueller-Premru M; Zidar N; Spik VC; Krope A; Kikelj D
Chemotherapy; 2009; 55(6):414-7. PubMed ID: 19955747
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
[TBL] [Abstract][Full Text] [Related]
16. Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program.
Jones RN;
Arch Pathol Lab Med; 2001 Oct; 125(10):1285-9. PubMed ID: 11570902
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
Matuschek E; Åhman J; Webster C; Kahlmeter G
Clin Microbiol Infect; 2018 Aug; 24(8):865-870. PubMed ID: 29221995
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of a commercial microbial control system.
Borchardt KA
Antimicrob Agents Chemother; 1976 May; 9(5):771-5. PubMed ID: 821389
[TBL] [Abstract][Full Text] [Related]
19. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Todisco T; Eslami A; Baglioni S; Sposini T; Tascini C; Sommer E; Knoch M
J Aerosol Med; 2000; 13(1):11-6. PubMed ID: 10947319
[TBL] [Abstract][Full Text] [Related]
20. Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria.
Miller RA; Walker RD; Carson J; Coles M; Coyne R; Dalsgaard I; Gieseker C; Hsu HM; Mathers JJ; Papapetropoulou M; Petty B; Teitzel C; Reimschuessel R
Dis Aquat Organ; 2005 May; 64(3):211-22. PubMed ID: 15997819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
